Search
Search Results
##search.searchResults.foundPlural##
-
IDENTİFİCATİON OF LEİSHMANİA TROPİCA FROM PEDİATRİC VİSCERAL LEİSHMANİASİS İN SOUTHERN MEDITERRANEAN REGION OF TURKEY. Molecular characterization of pediatric visceral leishmaniasis
1030PDF: 706HTML: 226 -
Allogeneic transplantation in patients with advanced systemic mastocytosis: case report of a single center experience Allogeneic Transplantation in Systemic Mastocytosis
1998PDF: 79HTML: 22 -
miR-155-5p PROMOTES CD34+ APOPTOSIS AND INHIBITS BONE MARROW HEMATOPOIESIS IN MYELODYSPLASTIC SYNDROMES BY RAC1/CREB/MIR-15B AXIS
754PDF: 881PDF Supp. Files: 79HTML: 193 -
PREVALENCE OF SERIOUS BACTERIAL INFECTIONS IN CHILDREN WITH SICKLE CELL DISEASE AT KING ABDULAZIZ HOSPITAL, AL AHSA Bacterial infections in children with sickle cell diseas
1592PDF: 604HTML: 222 -
HEMATOPOIETIC STEM CELL TRANSPLANTATION IN SEVERE PEDIATRIC SICKLE CELL DISEASE: OUTCOME AND LONG-TERM COMPLICATIONS, SAUDI EXPERIENCE AT KING FAISAL SPECIALIST HOSPITAL, RIYADH, SAUDI ARABIA HCT in in Severe Pediatric Sickle Cell Disease
1213PDF: 957HTML: 461 -
SEROPOSITIVITY OF HEPATITIS B AND C AMONG SYRIAN MULTITRANSFUSED PATIENTS WITH HEMOGLOBINOPATHY
2980PDF: 757HTML: 1122Cover Letter: 205 -
COST OF HEMATOPOIETIC STEM CELL TRANSPLANTATION IN INDIA
2782PDF: 980HTML: 4710 -
Identification of Alpha Thalassemia, RNF 213 p.R4810K and PROC p.R189W among Children with Moyamoya Disease/Syndrome Alpha Thalassemia and RNF 213 Gene Mutation in Moyamoya
989PDF: 733HTML: 239 -
PREVALENCE OF HEPATITIS B, HEPATITIS C AND HIV IN MULTIPLY TRANSFUSED SICKLE CELL DISEASE PATIENTS FROM OMAN HBV,HCV and HIV and Sickle Cell Disease.
1668PDF: 1014HTML: 371 -
HEMOGLOBIN ANALYSIS IN THE FIRST YEAR OF LIFE
3517PDF: 1043HTML: 3054 -
CHLORAMBUCIL PLUS RITUXIMAB AS FRONT-LINE THERAPY IN ELDERLY/UNFIT PATIENTS AFFECTED BY B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA: RESULTS OF A SINGLE-CENTRE EXPERIENCE.
3259PDF: 913HTML: 1544Fig.1 CHL-R paper: 227Fig 2 CHL-R paper: 249 -
QUALITY OF LIFE IN PATIENTS WITH THALASSEMIA MAJOR AND INTERMEDIA IN KERMAN-IRAN (I.R.)
1694PDF: 769HTML: 2345Cover Letter: 190 -
AGE AT DIAGNOSIS OF SICKLE CELL ANAEMIA IN LAGOS, NIGERIA
2026PDF: 910HTML: 1873 -
THALASSEMIA AND VENOUS THROMBOEMBOLISM
2951PDF: 1041HTML: 4597 -
CONCISE REVIEW ON THE FREQUENCY, MAJOR RISK FACTORS AND SURVEILLANCE OF HEPATOCELLULAR CARCINOMA (HCC) IN ?-THALASSEMIAS: PAST, PRESENT AND FUTURE PERSPECTIVES Thalassaemia transfusion dependent, Hepatitis C, hepatocarcinoma.
4306PDF: 1535HTML: 460 -
BACK TO THE “GOLD STANDARD”: HOW PRECISE IS HEMATOCRIT DETECTION TODAY? Novel ImageJ-based approach for the precise hematocrit measurement
2278PDF: 852HTML: 503 -
-
-
NON-SECRETORY MYELOMA: READY FOR A NEW DEFINITION?
3284PDF: 1722HTML: 1099 -
Ponatinib induced improvement of cutaneous lesions associated to accelerated phase of Ph-positive chronic myeloid leukemia
2933PDF: 698HTML: 1941figure 1: 177figure 2: 183 -
ULTRASOUND AS FIRST LINE STEP IN ANAEMIA DIAGNOSTICS
1414PDF: 898HTML: 1856 -
Massive pulmonary embolism at the onset of acute promyelocytic leukemia
3543PDF: 905HTML: 1665figure 1: 171Untitled: 197 -
SOCIAL IMPLICATIONS OF MALARIA AND THEIR RELATIONSHIPS WITH POVERTY
6152PDF: 3341HTML: 9031Figure Malaria Ricci: 236 -
The Outcome of Six Patients with COVID-19 Infection and Multiple Myeloma. A Case Series and Literature Review COVID-19 in Multiple Myeloma patients
1010PDF: 369HTML: 208 -
ADVERSE PREGNANCY OUTCOMES IN SICKLE CELL TRAIT: A PROSPECTIVE COHORT STUDY EVALUATING CLINICAL AND HAEMATOLOGICAL PARAMETERS IN POSTPARTUM MOTHERS AND NEW-BORNS. Sickle cell trait pregnancy and outcomes
1442PDF: 1244HTML: 487 -
PARASITIC INFECTIONS IN HEMATOPOIETIC STEM CELL TRANSPLANTATION
3728PDF: 1248HTML: 3909Untitled: 231Untitled: 267 -
NOVEL AGENTS AND EMERGING STRATEGIES FOR TARGETING THE B-CELL RECEPTOR PATHWAY IN CLL
2568PDF: 853HTML: 8903Efremov 1: 237Efremov 2: 203 -
The venetoclax/azacitidine combination targets the disease clone in Acute Myeloid Leukemia, being effective and safe in a patient with COVID VEN/AZA effectively targets AML clones
1284PDF: 773HTML: 321 -
Cardiac toxicity associated with HCV direct antiviral agents Heart in HCV DAAs therapy
1613PDF: 990HTML: 202







